Advertisement
Schizophrenia Research Series: Phenomenology and Pathophysiology| Volume 46, ISSUE 7, P921-928, October 01, 1999

Cognitive and functional changes with aging in schizophrenia

      Abstract

      The variation in functional outcome in schizophrenia appears to be exaggerated in late life. The cognitive and functional deficits commonly seen in younger schizophrenic patients appear to worsen in some cases in late life, while others patients appear to have a stable course of illness without functional decline, and still other patients have been reported to have essentially no residual symptoms in their later years. Cognitive and functional deficits appear to worsen more significantly in patients with a lifetime course of severe functional deficit. Despite the profound functional and cognitive deficits in these patients, neuropathologic studies have found no evidence of typical causes of severe cognitive impairments. This paper reviews the current findings on cognitive and functional changes in aging in schizophrenia, with a specific focus on patients with a poor lifetime functional outcome.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Addington J.
        • Addington D.
        Positive and negative symptoms of schizophrenia.
        Schizophr Res. 1991; 5: 51-59
        • Arnold S.E.
        • Gur R.E.
        • Shapiro R.M.
        • Fisher K.R.
        • Moberg P.J.
        • Gibney M.R.
        • et al.
        Prospective clinicopathologic studies of schizophrenia.
        Am J Psychiatry. 1995; 152: 731-737
        • Arnold S.E.
        • Trojanowski J.Q.
        • Gur R.E.
        • Blackwell P.
        • Han L.-Y.
        • Choi C.
        Absence of neurodegeneration and neural injury in the cerebral cortex in a sample of elderly patients with schizophrenia.
        Arch Gen Psychiatry. 1998; 55: 225-232
        • Bartels S.J.
        • Mueser K.T.
        • Miles K.M.
        Functional impairments in elderly patients with schizophrenia and major affective disorders living in the community.
        Behav Therapy. 1997; 28: 43-63
        • Berg L.
        Clinical Dementia Rating (CDR).
        Psychopharmacol Bull. 1988; 24: 637-639
        • Bilder R.M.
        • Lipschultz-Broch L.
        • Reiter G.
        • Geisler S.H.
        • Mayerhoff D.
        • Lieberman J.A.
        Intellectual deficits in first-episode schizophrenia.
        Schizophr Bull. 1992; 18: 437-448
        • Bleuler M.
        On schizophrenic psychoses.
        Am J Psychiatry. 1979; 136: 1403-1409
        • Breier A.
        • Schreiber J.L.
        • Dyer J.
        • et al.
        National Institute of Mental Health longitudinal study of chronic schizophrenia.
        Arch Gen Psychiatry. 1991; 48: 239-246
        • Bridge T.P.
        • Kleinman J.E.
        • Karoum F.
        • Wyatt R.J.
        Postmortem central catecholamines and ante mortem cognitive impairment in elderly schizophrenics and controls.
        Biol Psychiatry. 1985; 14: 57-61
        • Ciompi L.
        Catamnestic long-term study on the course of life and aging of schizophrenics.
        Schizophr Bull. 1980; 6: 606-618
        • Cohen C.I.
        Outcome of Schizophrenia into later life.
        Gerontologist. 1990; 30: 790-797
        • Crum R.M.
        • Anthony J.C.
        • Bassett S.S.
        • Folstein M.F.
        Population based norms for the Mini Mental Status Examination by age and education level.
        JAMA. 1993; 269: 2386-2391
        • Davidson M.
        • Harvey P.D.
        • Powchik P.
        • et al.
        Severity of symptoms in geriatric chronic schizophrenic patients.
        Am J Psychiatry. 1995; 152: 197-207
        • Davidson M.
        • Harvey P.D.
        • Welsh K.
        • et al.
        Cognitive impairment in old-age schizophrenia.
        Am J Psychiatry. 1996; 153: 1274-1279
        • Davis K.L.
        • Buchsbaum M.S.
        • Shihabuddin L.
        • et al.
        Ventricular enlargement in poor-outcome schizophrenia.
        Biol Psychiatry. 1998; 43: 783-793
        • DeLisi L.
        • Sakuma M.
        • Tew W.
        • Kushrer M.
        • Hoff A.
        • Grimson R.
        Schizophrenia as a chronic active brain process.
        Psychiatry Res Brain Imag. 1997; 74: 129-140
        • Folstein M.F.
        • Folstein S.E.
        • McHugh P.R.
        “Mini-mental state.” A practical method for grading the cognitive state of patients for the clinician.
        J Psychiatr Res. 1975; 12: 189-198
        • Freyhan F.A.
        Eugene Bleuler’s concept of the group of schizophrenia at mid-century.
        Am J Psychiatry. 1958; 137: 769-779
        • Goldberg T.
        • Hyde T.M.
        • Kleinman J.E.
        • Weinberger D.R.
        Course of schizophrenia.
        Schizophr Bull. 1993; 19: 787-804
        • Goldman H.H.
        • Feder J.
        • Scanlon W.
        Chronic mental patients in nursing homes.
        Hosp Comm Psychiatry. 1986; 37: 269-272
        • Green M.F.
        Cognitive remediation in schizophrenia.
        Am J Psychiatry. 1993; 150: 178-187
        • Green M.F.
        What are the functional consequences of neurocognitive deficits in schizophrenia?.
        Am J Psychiatry. 1996; 153: 321-330
        • Haas G.L.
        • Garratt L.S.
        • Sweeney J.A.
        Delay to first antipsychotic medication in schizophrenia.
        J Psychiatr Res. 1998; 32: 151-159
        • Harding C.M.
        • Brooks G.W.
        • Ashikaga T.
        • et al.
        The Vermont longitudinal study of persons with severe mental illness, I.
        Am J Psychiatry. 1987; 144: 718-726
        • Harding C.M.
        • Brooks G.W.
        • Ashikaga T.
        • et al.
        The Vermont Longitudinal study of persons with severe mental illness.
        Am J Psychiatry. 1987; 144: 727-735
        • Harding C.M.
        • Zubin J.
        • Strauss J.S.
        Chronicity in schizophrenia.
        Br J Psychiatry. 1992; 161: 27-37
        • Haroutunian V.
        • Davidson M.
        • Kanof P.D.
        • et al.
        Cortical cholinergic markers in schizophrenia.
        Schizophr Res. 1994; 12: 137-144
        • Harvey P.D.
        • Howanitz E.
        • Parrella M.
        • et al.
        Cognitive, adaptive, and clinical symptoms in geriatric patients with lifelong schizophrenia.
        Am J Psychiatry. 1998; 155: 1080-1086
        • Harvey P.D.
        • Leff J.
        • Trieman N.
        • Anderson J.
        • Davidson M.
        Cognitive impairment and adaptive deficit in geriatric chronic schizophrenic patients.
        Int J Geriatr Psychiatry. 1997; 12: 1001-1007
        • Harvey P.D.
        • Mohs R.C.
        • Davidson M.
        Leukotomy and aging in chronic schizophrenia.
        Schizophr Bull. 1993; 19: 723-732
        • Harvey P.D.
        • Silverman J.M.
        • Mohs R.C.
        • Powchik P.
        • Davidson M.
        • Davis K.L.
        Cognitive decline in late-life schizophrenia.
        Biol Psychiatry. 1999; 45: 32-40
        • Heaton R.
        • Paulsen J.S.
        • McAdams L.A.
        • et al.
        Neuropsychological deficits in schizophrenics.
        Arch Gen Psychiatry. 1994; 51: 469-476
        • Hoff A.L.
        • Riordan H.
        • O’Donnell D.W.
        • Morris L.
        • DeLisi L.
        Neuropsychological functioning in first-episode schizophreniform patients.
        Am J Psychiatry. 1992; 149: 898-903
        • Hyde T.M.
        • Nawroz S.
        • Goldberg T.E.
        • et al.
        Is there cognitive decline in schizophrenia? A cross sectional study.
        Br J Psychiatry. 1994; 164: 494-500
        • Jeste D.V.
        • Harris M.J.
        • Krull A.
        • Kuck J.
        • McAdams L.A.
        • Heaton R.
        Late-onset schizophrenia.
        Am J Psychiatry. 1995; 172: 722-730
        • Johnstone E.C.
        • Owens D.G.C.
        • Gold A.
        • Crow T.J.
        • Macmillan J.F.
        Institutionalization and the defects of schizophrenia.
        Br J Psychiatry. 1981; 139: 195-203
        • Keefe R.S.E.
        • Mohs R.C.
        • Losonczy M.F.
        • et al.
        Characteristics of very poor outcome schizophrenia.
        Am J Psychiatry. 1987; 144: 889-894
        • Khachaturian Z.S.
        Diagnosis of Alzheimer’s disease.
        Arch Neurol. 1985; 42: 1097-1105
        • Klapow J.
        • Evans J.
        • Patterson T.L.
        • et al.
        Direct assessment of functional status in older patients with schizophrenia.
        Am J Psychiatry. 1997; 154: 1022-1024
        • Leff J.P.
        • Thornicroft G.
        • Coxhead N.
        • et al.
        The TAPS Project. 22.
        Br J Psychiatry. 1994; 165: 13-17
        • Lindstrom L.H.
        Clinical and biological markers for outcome in schizophrenia.
        Neuropsychopharmacology. 1996; 14: 23S-26S
        • McKenna P.J.
        • Lund C.E.
        • Mortimer A.M.
        Negative symptoms.
        Br J Psychiatry. 1989; 155: 104-107
        • Morris J.C.
        • Edland S.
        • Clark C.
        • et al.
        The consortium to establish a registry for Alzheimer’s disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer’s disease.
        Neurology. 1993; 43: 2457-2465
        • Paulsen J.S.
        • Heaton R.K.
        • Sadek J.R.
        • Perry W.
        • Jeste D.V.
        The nature of learning and memory impairments in schizophrenia.
        J Int Neuropsychol Soc. 1995; 1: 88-99
        • Powchik P.
        • Davidson M.
        • Haroutunian V.
        • et al.
        Postmortem studies in schizophrenia.
        Schizophr Bull. 1998; 24: 325-341
        • Purohit D.P.
        • Perl D.P.
        • Haroutunian V.
        • Powchik P.
        • Davidson M.
        • Davis K.L.
        Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia.
        Arch Gen Psychiatry. 1998; 55: 205-211
        • Rapoport J.L.
        • Giedd J.
        • Kumar S.
        • et al.
        Childhood onset schizophrenia.
        Arch Gen Psychiatry. 1997; 54: 897-903
        • Saykin A.J.
        • Shtasel D.L.
        • Gur R.E.
        • Kester D.B.
        • Mozley L.H.
        • Stafiniak P.
        • Gur R.C.
        Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia.
        Arch Gen Psychiatry. 1994; 51: 124-131
        • Selemon L.D.
        • Goldman-Rakic P.S.
        The reduced neuropil hypothesis.
        Biol Psychiatry. 1999; 45: 17-25
        • Shapiro R.M.
        Regional neuropathology in schizophrenia.
        Schizophr Res. 1993; 10: 187-239
        • Trojanowski J.Q.
        • Growdon J.H.
        A new consensus report on biomarkers for the early antemortem diagnosis of Alzheimer disease.
        J Neuropathol Exper Neurol. 1998; 57: 643-644
        • Wieselgren I.M.
        • Lindstrom L.H.
        A prospective 1–5 year outcome study in first-admitted and readmitted schizophrenic patients.
        Acta Psychiatr Scand. 1996; 93: 9-19
        • Wolf S.S.
        • Hyde T.M.
        • Weinberger D.R.
        Neurobiology of schizophrenia.
        Curr Opin Neurol Neurosurg. 1993; 6: 86-92
        • Wyatt R.J.
        • Henter I.D.
        The effects of early and sustained intervention on the long-term morbidity of schizophrenia.
        J Psychiatric Res. 1998; 32: 169-177